Wednesday, March 08, 2023 5:38:59 PM
Just listened to the OPRX conference call. They've showed decreases in revenues the last two quarters and are forecasting another drop in Q1's (about 11%) revenue. They are forecasting an increase of over 10% growth for this year. That means robust revenues are to be recognized in Q's 2, 3 and 4.
Keep in mind OptimizerX is targeting a $10 billion market. If we, in fact, have the best solution for a customer's ROI, it has to be realized in increased volumes and profits someday. The pace, or lack thereof, is maddening.
Of particular concern is the increased costs that continue to damage the profitability of this company. The COO said costs will increase in Q1/23 as revenues are forecasted to shrink in that quarter . Noteworthy is that they are doing buybacks of their stock. They reduced the share count from barely over 18 million to just above 17 million. This was a 7% reduction but cost the bottom line over $1.2 million. One has to ask why this is deemed significant when the stock has lost so much value over the last 12 months. Wouldn't a profitable OPRX seem more desirable to own than one with a million less shares? This puzzles me.
Keep in mind OptimizerX is targeting a $10 billion market. If we, in fact, have the best solution for a customer's ROI, it has to be realized in increased volumes and profits someday. The pace, or lack thereof, is maddening.
Of particular concern is the increased costs that continue to damage the profitability of this company. The COO said costs will increase in Q1/23 as revenues are forecasted to shrink in that quarter . Noteworthy is that they are doing buybacks of their stock. They reduced the share count from barely over 18 million to just above 17 million. This was a 7% reduction but cost the bottom line over $1.2 million. One has to ask why this is deemed significant when the stock has lost so much value over the last 12 months. Wouldn't a profitable OPRX seem more desirable to own than one with a million less shares? This puzzles me.
Bullish
Recent OPRX News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/01/2026 11:30:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:44:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 08:43:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 08:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:07:01 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 11:16:29 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 11:15:41 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 02:57:29 PM
- OptimizeRx Appoints Mary Varghese Presti to Board of Directors • GlobeNewswire Inc. • 04/08/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:29:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/12/2026 08:03:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:09:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2026 04:49:55 PM
- OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing • GlobeNewswire Inc. • 01/07/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 09:53:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 09:52:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 03:10:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 03:10:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 03:09:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 03:08:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 03:07:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/22/2025 03:07:15 PM
- OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network • GlobeNewswire Inc. • 12/17/2025 09:30:00 AM
